10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 359,284 | 222,379 | 588,475 | 680,170 | 424,166 |
| Marketable Securities | 29,411 | 210,238 | N/A | N/A | N/A |
| Receivables | 114,832 | 104,211 | 85,254 | 51,208 | 33,371 |
| Inventories | 73,706 | 81,629 | 59,966 | 29,959 | 15,270 |
| TOTAL | $596,022 | $635,035 | $747,591 | $774,366 | $480,840 |
| Non-Current Assets | |||||
| PPE Net | 279,571 | 289,328 | 169,492 | 72,840 | 48,821 |
| Intangibles | 21,127 | 27,369 | 29,908 | 22,354 | 0 |
| Other Non-Current Assets | 68,423 | 77,248 | 71,835 | 59,781 | 76,262 |
| TOTAL | $369,121 | $393,945 | $271,235 | $154,975 | $125,083 |
| Total Assets | $965,143 | $1,028,980 | $1,018,826 | $929,341 | $605,923 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 9,882 |
| Accounts payable and accrued liabilities | 15,738 | 21,599 | 17,351 | 4,709 | 13,028 |
| Accrued Expenses | 86,753 | 92,454 | 82,535 | 103,009 | 36,842 |
| TOTAL | $127,162 | $130,957 | $110,357 | $118,126 | $63,049 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 19,837 |
| Deferred Revenues | 13,150 | 7,867 | 5,340 | 4,472 | 3,297 |
| aiOther Non-Current Liabilities | 88,124 | 89,115 | 90,901 | 72,143 | 86,834 |
| TOTAL | $96,938 | $92,280 | $90,901 | $72,143 | $122,791 |
| Total Liabilities | $224,100 | $223,237 | $201,258 | $190,269 | $185,840 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 119,167 | 115,357 | 112,845 | 108,753 | N/A |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,284,420 | -1,029,321 | -863,321 | -805,098 | -262,367 |
| Other shareholders' equity | -429 | -4,335 | 22 | -50 | -46 |
| TOTAL | $741,043 | $805,743 | $817,568 | $739,072 | $420,083 |
| Total Liabilities And Equity | $965,143 | $1,028,980 | $1,018,826 | $929,341 | $605,923 |